RUSSIAN NATIONAL SCIENTIFIC ANATOMICAL JOURNAL

Preview

Morphological newsletter

Advanced search

ANTHROPOMETRIC AND BIO-IMPEDANSOMETRIC PARAMETERS AS DIAGNOSTIC PREDICTORS IN PATIENTS WITH GASTRIC CANCER

https://doi.org/10.20340/mv-mn.2020.28(4):473

Abstract

The study of anthropometric and bioimpedance parameters in assessing the physical development of patients helps to clarify the diagnosis, predict the course of the disease, and identify groups of increased risk for the development of the disease. The aim of this study was to identify anthropometric and bioimpedance metrics in patients with stomach cancer. Anthropometric and bioimpedansometric examination of 250 patients with verified gastric cancer, 123 men and 127 women was carried out. As a comparison group, the study used the results of anthropometric and bioimpedance measurements of healthy 221 men and 267 women of the same age in the Krasnoyarsk Territory population. To determine a set of anthropometric and bioimpedansometric variables, allowing to classify the observed people depending on the presence (group of patients with gastric cancer) or the absence of stomach cancer (group of healthy people), the method of discriminant analysis was applied. To test the hypothesis about the homogeneity of the covariance matrices of the compared groups, the multidimensional Box M-criterion was used. The statistical significance of the power of the discriminant function was assessed using the Wilks test. For each discriminant function, the role of its components was assessed by comparing the matrices of total variances and covariances using the F-test. Shoulder diameter for men and women, chest diameter (transverse size) for men and women, waist circumference for men, waist / hip ratio for men and women; lean mass in men, total fluid in men, fat mass in women, phase angle in men and women are statistically significantly different in the observed groups. The developed discriminant models with an accuracy of 75-77% suggest the presence of gastric cancer in patients and can be used in clinical practice at the stage of general medical examination in groups at increased risk of developing the disease.

About the Authors

Ekaterina A. Gorbunova
Kryzhanovsky Krasnoyarsk Regional Clinical Oncology Dispensary, Krasnoyarsk
Russian Federation
oncologist, Head of the department of common oncology of the polyclinic
Competing Interests: The author declares that he has no conflicts of interest in the planning, execution, financing and use of this publication


Armen R. Karakhanyan
Professor Voyno-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk
Russian Federation
6th year student of the Faculty of GP
Competing Interests: The author declares that he has no conflicts of interest in the planning, execution, financing and use of this publication


Yana A. Yankina
Professor Voyno-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk
Russian Federation
4th year student of the Faculty of GP
Competing Interests: The author declares that he has no conflicts of interest in the planning, execution, financing and use of this publication


Nadezhda N. Medvedeva
Professor Voyno-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk
Russian Federation
Doctor of Medical Sciences, Professor, Head of the Department of the Human Anatomy
Competing Interests: The author declares that he has no conflicts of interest in the planning, execution, financing and use of this publication


Ruslan A. Zukov
Professor Voyno-Yasenetsky Krasnoyarsk State Medical University, Kryzhanovsky Krasnoyarsk Regional Clinical Oncology Dispensary, Krasnoyarsk
Russian Federation
Doctor of Medical Sciences, Professor, Head of the Department of Oncology and Radiation Therapy with a course of postgraduate education of the Professor Voino-Yasenetsky Krasnoyarsk State Medical University; oncologist of the Kryzhanovsky Krasnoyarsk Regional Clinical Oncological Dispensary
Competing Interests: The author declares that he has no conflicts of interest in the planning, execution, financing and use of this publication


References

1. Gajvoronskij IV, Nichiporuk GI, Gajvoronskij IN, Nichiporuk NG. Bioimpedansometrija kak metod ocenki komponentnogo sostava tela cheloveka (obzor literatury). Vestnik Sankt-Peterburgskogo universiteta. Medicina. 2017;12(4):365-384. DOI:org/10.21638/11701/spbu11.2017.406

2. Tomaeva KG, Gajdukov SN. Izuchenie modeli prognozirovanija riska razvitija prejeklampsii u zhenshhin s raznymi somatotipami. Zhurnal akusherstva i zhenskih boleznej. 2019: 68(6):65–72. DOI: org/10.17816/JOWD68665-72

3. Jeong S , Lee DH, Giovannucci EL. Predicted lean body mass, fat mass and risk of lung cancer: prospective US cohort study. European Journal of Epidemiology. 2019; 34(12):1151-1160. DOI: 10.1007/s10654-019-00587-2

4. Britton KA, Massaro JM, Murabito JM, Kreger BE, Hoffmann U, Fox CS. Body Fat Distribution, Incident Cardiovascular Disease, Cancer, and All-cause Mortality. J. Am. Coll. Cardiol. 2013;62:921–925. DOI: 10.1016/j.jacc.2013.06.027.

5. Jancen AK, Gattermann T, Fink TJ, Saldanha MF, Rocha CD, Moreira TH, Silva FM. Low standardized phase angle predicts prolonged hospitalization in critically ill patients. Clin Nutr ESPEN. 2019;34:68-72. DOI: 10.1016/j.clnesp.2019.08.011.

6. Wang WL , Liang S , Zhu FL , Liu JQ, Chen XM, Cai GY. Association of the malnutrition-inflammation score with anthropometry and body composition measurements in patients with chronic kidney disease. Ann Palliat Med. 2019;8(5):596-603. DOI:10.21037/apm.2019.10.12.

7. Pahomova RA, Karapetjan GJe, Kochetova LV, Sindeeva LV, Ratushnyj NA, Zjuzjukina AV. Pokazateli morfometrii molochnyh zhelez zhenshhin raznyh somatotipov v norme i pri rake molochnoj zhelezy. Jakutskij medicinskij zhurnal. 2020;68(4):126-128.

8. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371(9612):569–78. DOI: org/10.1016/s0140-6736(08)60269-x

9. Andreasson A, Hagström H, Sköldberg F, Önnerhag K, Carlsson AC, Schmidt PT, Forsberg AM. The prediction of colorectal cancer using anthropometric measures: A Swedish population-based cohort study with 22 years of follow-up. United European Gastroenterol J. 2019; 7(9):1250-1260. DOI: 10.1177/2050640619854278.

10. Kabat GC, Xue X, Kamensky V, Lane D, Bea JW, Chen C, Qi L, Stefanick ML, Chlebowski RT, Wactawski-Wende J, Wassertheil-Smoller S, Rohan TE. Risk of breast, endometrial, colorectal, and renal cancers in postmenopausal women in association with a body shape index and other anthropometric measures. Cancer Causes Control. 2015;26(2):219-229. DOI: 10.1007/s10552-014-0501-4

11. Li HB, Cheng H, Hou DQ, Gao AY, Zhu ZX, Yu ZC, Wang HJ, Zhao XY, Xiao P, Huang GM, Mi J. Value of body fat mass measured by bioelectrical impedance analysis in predicting abnormal blood pressure and abnormal glucose metabolism in children. Zhongguo Dang Dai Er Ke Za Zhi. 2020;22(1):17-23. PMID: 31948519

12. Bunak VV. Metodika antropometricheskih issledovanij. Moskva: Gosmedizdat; 1931. 168s.

13. Bray F, Ferlay J, Soerjomataram I. et al. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians. 2018;0:1–31.

14. Kaprin AD, Starinskij VV, Petrova GV (eds.): Sostojanie onkologicheskoj pomoshhi naseleniju Rossii v 2018 godu. Moskva: MNIOI im. P.A. Gercena − filial FGBU «NMIC radiologii» Minzdrava Rossii; 2019. 236s.

15. Petrovchich I, Ford JM. Genetic predisposition to gastric cancer. J SeminOncol 2016;43(5):554–9.

16. Cheng XJ, Lin JC, Tu SP. Etiology and Prevention of Gastric Cancer. Gastrointest Tumors. 2016. 3(1):25-36. DOI: 10.1111/hel.12643.

17. Venerito M, Link A, Rokkas T, Malfertheiner P. Review: Gastric cancer-Clinical Aspects. Helicobacter. 2016:21: 39-44.

18. DOI: 10.1111/hel.12339

19. Matusik E, Augustak A, Durmala J Functional Mobility and Basic Motor Skills in Patients with Multiple Sclerosis and Its Relation to the Anthropometrical Status and Body Composition Parameters. Medicina (Kaunas). 2019:4;55(12):773. DOI: 10.3390/medicina55120773

20. Wei LP, Li N , Wang G , Wen Y, Lyu ZY , Feng XS , Li X, Chen YH , Chen HD, Chen SH , Ren JS, Shi JF , Cui H , Wu SL , Dai M , He J. Progress in Epidemiologic Research of Association Between Anthropometric Indicators and Risk for Gastric Cancer. Zhonghua Liu Xing Bing Xue Za Zhi. 2019:10;40(11):1481-1486. DOI: 10.3760/cma.j.issn.0254-6450.2019.11.025.

21. Medvedeva NN, Nikolaev VG, Derevcova SN, Sindeeva LV, Romanenko AA, Petrova MM, Shnajder NA, Shul'min AV. Ocenka somatonejropsihologicheskogo zdorov'ja cheloveka. Sibirskoe medicinskoe obozrenie. 2016;(3):73-80


Supplementary files

The authors of the article have established that the values of a number of anthropometric and bioimpedansometric indicators that distinguish patients with stomach cancer from healthy people can be used in clinical practice at the stage of clinical examination to identify individuals with an increased risk of developing this disease

Review

For citations:


Gorbunova E.A., Karakhanyan A.R., Yankina Ya.A., Medvedeva N.N., Zukov R.A. ANTHROPOMETRIC AND BIO-IMPEDANSOMETRIC PARAMETERS AS DIAGNOSTIC PREDICTORS IN PATIENTS WITH GASTRIC CANCER. Morphological newsletter. 2020;28(4):18-24. (In Russ.) https://doi.org/10.20340/mv-mn.2020.28(4):473

Views: 541


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1812-3171 (Print)
ISSN 2686-8741 (Online)